Serum Copeptin and Zinc-α2-glycoprotein Levels Are Novel Biomarkers of Tolvaptan Treatment in Decompensated Cirrhotic Patients with Ascites

OBJECTIVE: The efficacy of tolvaptan, an orally active vasopressin V2-receptor antagonist, has recently been reported in patients with massive ascites unresponsive to conventional diuretics. However, the effect of tolvaptan varies among patients. Recently, the prognostic role of the tolvaptan respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigefuku, Ryuta, Iwasa, Motoh, Eguchi, Akiko, Tempaku, Mina, Tamai, Yasuyuki, Suzuki, Tatsuya, Takei, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627803/
https://www.ncbi.nlm.nih.gov/pubmed/34719623
http://dx.doi.org/10.2169/internalmedicine.7291-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627803/
https://www.ncbi.nlm.nih.gov/pubmed/34719623
http://dx.doi.org/10.2169/internalmedicine.7291-21

Ejemplares similares